Cancilico

Cancilico is a German technology company pioneering AI in healthcare by developing automated diagnostic solutions for medical research and laboratory infrastructure. The headquarters location is not specified on the website.

Here are key aspects of the company:

• Products & Services: MyeloAID, a flagship AI software product that automates the classification and counting of cells in bone marrow samples to create detailed myelograms rapidly.
• Industries: The company serves the medical research community by addressing challenges such as rare cell type identification and integrating with existing laboratory infrastructure.
• Innovation: Cancilico utilizes advanced AI algorithms to enhance diagnostic precision while significantly reducing the time and labor traditionally involved in hematological examinations.

Cancilico is transforming diagnostics through its commitment to quality, continuous improvement, and high-value outcomes for evolving medical needs.